HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 03-29-2007, 09:21 AM   #1
Grace
Guest
 
Posts: n/a
Further to Muga vs Echo. I just had an echo and my LVEF, measured three times, was 63, 61, 62, which is just about what my Muga's have been showing. The technician also looked extensively at right ventricle and the full heart, contractions, etc.,but I don't yet have the radiologist's report on that, which is my main concern. However, the technician did tell me that they don't measure right ventricle flow, as it would be too difficult to measure, and that the left is really the important measurement with respect to EF. And, finally, the echo was so much easier to do, no needles, and no approvals needed from my insurance. So echo is the way I plan to go in the future.
  Reply With Quote
Old 03-29-2007, 01:07 PM   #2
Barbara2
Senior Member
 
Barbara2's Avatar
 
Join Date: Sep 2005
Location: South Dakota.
Posts: 621
Monitoring the Heart

The following is from the current issue (Spring 2007) of the CURE magazine:

Monitoring the Heart
Patients receiving potentially cardiotoxic cancer therapy should be carefully monitored both during and after treatment. An echocardiogram (heart ultrasound) is the primary tool used to monitor heart health, but other tests may also be done, including blood tests, electrocardiograms or multiple-gated acquisition (MUGA) scans, which produce a moving image of the heart muscle.

M.D. Anderson Cancer Center's department of cardiology recently sponsored a panel discussion of oncologists and cardiologists to discuss how to best monitor a patient's heart function. Concerning the issue of whether to use non-invasive echocardiogram or time-consuming yet genearally more precise MUGA, the panel determined either imaging method was acceptable depending on the expertise of the radiologists and cardiologists at a particular cancer center.

Following treatment, survivors should have a yearly checkup to identify any long-term consequences of cancer therapy. Those at higher risk for heart complications may need more frequent monitoring.
__________________
Blessings and Peace,
Barbara

DX Oct 02 @ age 52 Stage 2B Grade 3 Mastectomy
"at least" 4.5 cm IDC 1+node ER+61% /PR-
Assiciated Intraductual component with Comedo Necrosis
Her2+ FISH8.6 IHC 2+
5 1/2 CEF Arimidex
Celebrex 400mg daily for 13 months
Prophylactic mastectomy
Estradiol #: 13
PTEN positive, "late" Herceptin (26 months after chemo)
Oct 05: Actonel for osteopenia from Arimidex.
May 08: Replaced Actonel with Zometa . Taking every 6
months.

Accepting the gift of life, I give thanks for it and live it in fullness.
Barbara2 is offline   Reply With Quote
Old 04-04-2007, 02:06 PM   #3
Grace
Guest
 
Posts: n/a
I finally received my report from my echo (which was done in lieu of a MUGA as my last MUGA indicated that I had right ventricle hypokinesis). The echo was much easier on me (my veins were protesting) and the echo report gives more information than the MUGA did. LVEF is down some, 60% from 63%, which is fine, and all my other measurements were in the normal range. New to me though was the pronouncement that I have "prominent epicardial fat," so another thing to worry about. And how did I feed that worry?--with a large piece of iced pound cake. Tomorrow . . .
  Reply With Quote
Old 04-04-2007, 08:37 PM   #4
Bev
Senior Member
 
Join Date: Dec 2005
Location: Alexandria, VA
Posts: 1,055
I asked to be switched to echo's when I saw others here were doing it. The only reason for a muga in my mind would be if you were fresh from surgery and couldn't tolerate the transducer being rubbed on your scar. I've done at least 2 of each and echo has my vote. BB
Bev is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 10:27 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter